Amazon Health Services plans to restructure and refocus on progressive innovation following numerous acquisitions, launches, and the telehealth business closure over seven years. Following recent senior departures, leadership from within will oversee several divisions. This change in strategy comes as Amazon continues to grow its pharmacy business, having expanded operations, introduced drone delivery and negotiated deals with pharmaceutical firms.
BioCryst’s $700M Astria Acquisition Gives It a Shot to Beat Larger Rivals in Rare Disease HAE
BioCryst Pharmaceuticals’ Astria Therapeutics acquisition brings navenibart, a drug in Phase 3 testing for the rare disease hereditary angioedema. The injectable antibody has the potential
